| Catalog No. | Size | Price (USD) |
| 40010-T62-20 | 20 µL | $118.49 |
| 40010-T62-50 | 50 µL | $222.17 |
| 40010-T62-100 | 100 µL | $370.28 |
General Information
| Product name | Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 Antibody, Rabbit PAb, Antigen Affinity Purified |
| Validated applications | WB (FAQ Protocol), ELISA (FAQ Protocol) |
| Application notes | IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.) |
| Specificity | Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 |
| Immunogen | Recombinant Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 Protein (Catalog#40010-V07E) |
| Preparation | Produced in rabbits immunized with purified, recombinant Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 (Catalog#40010-V07E; NP_040978.1; Ser2-Lys252). Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 specific IgG was purified by Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A & Antigen Affinity |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Image / Experimental Information
| Image 1 Description | Anti-Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 rabbit polyclonal antibody at 1:1000 dilution. Sample:Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Matrix protein 1 / M1 Recombinant Protein Lane A: 30ng Secondary HRP Conjugated Goat anti-rabbit IgG (H+L) at 1/1000 dilution Performed under reducing conditions. |
| Image 1 Alt Text | H1N1 Influenza M1/matrix protein 1 Western blot (WB) 13615 |
| Image 1 URL | Source image |
Background Information
| Full Name | cholinergic receptor, muscarinic 1 |
| Description | The Influenza virus matrix protein 1 (M1) is a matrix protein of the influenza virus. M1 protein has been shown to play a crucial role in virus replication, assembly, and budding. It forms a coat inside the viral envelope. This is a bifunctional membrane/RNA-binding protein that mediates the encapsidation of RNA-nucleoprotein cores into the membrane envelope. M1 consists of two domains connected by a linker sequence. The N-terminal domain has a multi-helical structure. The C-terminal domain also contains an alpha-helical structure. The M1 protein is the most abundant structural protein in influenza A virus particles. M1 protein of the influenza A virus plays multiple roles in virion assembly and infection. M1 protein was a candidate antigen for a broad-spectrum influenza virus vaccine and the adjuvant chitosan significantly improved the efficacy of the M1 vaccine. |
title: Intranasal Delivery of an RSV A2-Derived Pre-F VLP Vaccine Induces Robust Mucosal and Systemic Immunity Against RSV B Strain Without Enhanced Disease
authors: Arun Meas; Young Hun Kim; ...; Hye Suk Hwang
journal: Immune Network
date: 2026-06-01
pmid: 42405215
doi: 10.4110/in.2026.26.e19
cited_by_count: 0
techniques: Activity Assay; Binding Assay; Construct; Electron Microscopy; Expressing; Generated; Staining; Vaccines; Virus; Western Blot
bioz_score: 94
title: Influenza A Virus Induces Autophagosome by Inhibiting LTCC/Calpain 2/LC3A Signaling to Promote Viral Replication.
authors: Lu Tian; Xueer Liu; ...; Jiangtao Sheng
journal: Journal of medical virology
date: 2025-05-13
pmid: 40358023
doi: 10.1002/jmv.70393
cited_by_count: 1
bioz_score: 94
title: Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection.
authors: Jinying Shen; Jing Li; ...; Longlong Si
journal: Nature Microbiology
date: 2025-02-04
pmid: 39815008
doi: 10.1038/s41564-024-01908-2
cited_by_count: 11
techniques: Co-Immunoprecipitation Assay; Incubation; Infection; Knockdown; TCID50 Assay; Transfection; Virus; Western Blot
bioz_score: 94
title: Sec10 negatively regulates antiviral immunity by downregulating NRF2-ATF4-RIG-I axis
authors: Peili Hou; Fuzhen Zhang; ...; Hongbin He
journal: International Journal of Biological Sciences
date: 2025-01-01
cited_by_count: 0
bioz_score: 94
title: Baicalin inhibits influenza A (H1N1)-induced pyroptosis of lung alveolar epithelial cells via caspase-3/GSDME pathway.
authors: Zhenqiao Wei; Rui Gao; ...; Shengqi Wang
journal: Journal of medical virology
date: 2023-05-23
pmid: 37212338
doi: 10.1002/jmv.28790
cited_by_count: 26
bioz_score: 94
title: Lidocaine inhibits influenza a virus replication by up-regulating IFNα4 via TBK1-IRF7 and JNK-AP1 signaling pathways.
authors: Xueer Liu; Fengqing Zheng; ...; Jiangtao Sheng
journal: International Immunopharmacology
date: 2023-02-08
pmid: 36638664
doi: 10.1016/j.intimp.2023.109706
cited_by_count: 4
techniques: Western Blot
bioz_score: 94
-HB05NO1614-WB.png){kind=link}